Search Results - "Revicki, D. A."

Refine Results
  1. 1

    The Impact of Measuring Patient-Reported Outcomes in Clinical Practice: A Systematic Review of the Literature by Valderas, J. M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C. E., Halyard, M. Y., Revicki, D. A., Symonds, T., Parada, A., Alonso, J.

    Published in Quality of life research (01-03-2008)
    “…Objective The purpose of this paper is to summarize the best evidence regarding the impact of providing patientreported outcomes (PRO) information to health…”
    Get full text
    Journal Article
  2. 2

    Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index by Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., Tack, J.

    Published in Alimentary pharmacology & therapeutics (01-07-2003)
    “…Summary Background : Patient‐based symptom assessments are necessary to evaluate the effectiveness of medical treatments for gastroparesis. Aim : To summarize…”
    Get full text
    Journal Article
  3. 3

    Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory by Gordon, K.B., Kimball, A.B., Chau, D., Viswanathan, H.N., Li, J., Revicki, D.A., Kricorian, G., Ortmeier, B.G.

    Published in British journal of dermatology (1951) (01-03-2014)
    “…Summary Background Psoriasis symptoms have a significant negative impact on health‐related quality of life, impairing physical functioning and well‐being…”
    Get full text
    Journal Article
  4. 4

    Development and Psychometric Evaluation of the Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) in Patients with upper Gastrointestinal Disorders by A. M. Rentz, P. Kahrilas, V. Stanghellini, J. Tack, N. J. Talley, C. de la Loge, E. Trudeau, Dubois, D., D. A. Revicki

    Published in Quality of life research (01-12-2004)
    “…Objective: Describe the development and evaluation of a new self-report instrument, the patient assessment of upper gastrointestinal disorders-symptom severity…”
    Get full text
    Journal Article
  5. 5

    Development and content validity of a gastroparesis cardinal symptom index daily diary by REVICKI, D. A., CAMILLERI, M., KUO, B., NORTON, N. J., MURRAY, L., PALSGROVE, A., PARKMAN, H. P.

    Published in Alimentary pharmacology & therapeutics (15-09-2009)
    “…Summary Background  The Gastroparesis Cardinal Symptom Index (GCSI) is a patient‐reported outcome for gastroparesis using a two‐week recall period. To minimize…”
    Get full text
    Journal Article
  6. 6

    Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD) by Revicki, D. A., Camilleri, M., Kuo, B., Szarka, L. A., McCormack, J., Parkman, H. P.

    Published in Neurogastroenterology and motility (01-05-2012)
    “…Background  Patient‐reported symptom scales are needed to evaluate treatments for gastroparesis. The Gastroparesis Cardinal Symptom Index‐Daily Diary (GCSI‐DD)…”
    Get full text
    Journal Article
  7. 7

    Recommendations on Health-Related Quality of Life Research to Support Labeling and Promotional Claims in the United States by D. A. Revicki, D. Osoba, D. Fairclough, I. Barofsky, R. Berzon, N. K. Leidy, Rothman, M.

    Published in Quality of life research (01-01-2000)
    “…Health-related quality of life (HRQL) outcomes evaluation is becoming an important component of clinical trials of new pharmaceuticals and medical devices…”
    Get full text
    Journal Article
  8. 8

    PROMIS computerised adaptive tests are dynamic instruments to measure health‐related quality of life in patients with cirrhosis by Bajaj, J. S., Thacker, L. R., Wade, J. B., Sanyal, A. J., Heuman, D. M., Sterling, R. K., Gibson, D. P., Stravitz, R. T., Puri, P., Fuchs, M., Luketic, V., Noble, N., White, M., Bell, D., Revicki, D. A.

    Published in Alimentary pharmacology & therapeutics (01-11-2011)
    “…Aliment Pharmacol Ther 2011; 34: 1123–1132 Summary Background  Cirrhotic patients have an impaired health‐related quality of life (HRQOL), which is usually…”
    Get full text
    Journal Article
  9. 9

    United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument by King, Madeleine T., Revicki, D. A., Norman, R., Müller, F., Viney, R.C., Pickard, A. S., Cella, D., Shaw, J. W.

    Published in PharmacoEconomics - open (01-01-2024)
    “…Objectives To develop a value set reflecting the United States (US) general population’s preferences for health states described by the Functional Assessment…”
    Get full text
    Journal Article
  10. 10

    Patient assessment of treatment satisfaction: methods and practical issues by Revicki, D A

    Published in Gut (01-05-2004)
    “…Measurement of treatment satisfaction in gastro-oesophageal reflux disease (GORD) is compromised by an insufficient conceptual foundation and poor assessment…”
    Get full text
    Journal Article
  11. 11

    Evidence for Reliability, Validity and Usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) by A. W. Wu, D. A. Revicki, Jacobson, D., F. E. Malitz

    Published in Quality of life research (01-08-1997)
    “…The Medical Outcomes Study HIV Health Survey (MOS-HIV) is a brief, comprehensive measure of health-related quality of life (HRQoL) used extensively in human…”
    Get full text
    Journal Article
  12. 12

    The development and validation of a Nocturnal Gastro‐oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults by Spiegel, B. M., Roberts, L., Mody, R., Harding, G., Kothari‐Talwar, S., Kahrilas, P. J., Camilleri, M. L., Dabbous, O., Revicki, D. A.

    Published in Alimentary pharmacology & therapeutics (01-08-2010)
    “…Aliment Pharmacol Ther 2010; 32: 591–602 Summary Background  Current questionnaires for assessing gastro‐oesophageal reflux disease (GERD) symptoms are limited…”
    Get full text
    Journal Article
  13. 13

    The impact of gastroesophageal reflux disease on health-related quality of life by Revicki, D A, Wood, M, Maton, P N, Sorensen, S

    Published in The American journal of medicine (01-03-1998)
    “…Gastroesophageal reflux disease (GERD) affects health-related quality of life. We enrolled 533 adults with a history of heartburn symptoms for at least 6…”
    Get more information
    Journal Article
  14. 14

    The content validity of the PSS in patients with plaque psoriasis by Rentz, A. M., Skalicky, A. M., Burslem, K., Becker, K., Kaschinski, D., Esser, D., Revicki, D. A.

    Published in Journal of patient-reported outcomes (01-01-2017)
    “…Background The primary objective of this study was to evaluate the content validity of the Psoriasis Symptom Scale (PSS), with a specific focus on…”
    Get full text
    Journal Article
  15. 15

    Health Status Assessment for the Twenty-First Century: Item Response Theory, Item Banking and Computer Adaptive Testing by REVICKI, D.A, CELLA, D.F

    Published in Quality of life research (01-08-1997)
    “…Health status assessment is frequently used to evaluate the combined impact of human immunodeficiency virus (HIV) disease and its treatment on functioning and…”
    Get full text
    Journal Article
  16. 16

    Validity and Responsiveness of the EuroQol as a Measure of Health-Related Quality of Life in People Enrolled in an AIDS Clinical Trial by A. W. Wu, D. L. Jacobson, K. D. Frick, Clark, R., D. A. Revicki, K. A. Freedberg, J. Scott-Lennox, Feinberg, J.

    Published in Quality of life research (01-05-2002)
    “…Objective: Brief utility measures are needed in clinical trials in addition to existing descriptive measures of health-related quality of life (HRQOL). We…”
    Get full text
    Journal Article
  17. 17

    Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index by Revicki, D A, Leidy, N K, Brennan-Diemer, F, Sorensen, S, Togias, A

    Published in Chest (01-10-1998)
    “…To develop and evaluate a brief, easy-to-administer symptom assessment scale for use as a preference-based outcome measure in clinical trials and…”
    Get more information
    Journal Article
  18. 18

    Complete resolution of heartburn symptoms and health‐related quality of life in patients with gastro‐oesophageal reflux disease by REVICKI, D. A, CRAWLEY, J. A, ZODET, M. W, LEVINE, D. S, JOELSSON, B. O

    Published in Alimentary pharmacology & therapeutics (01-12-1999)
    “…Background: Medical treatments for gastro‐oesophageal reflux disease (GERD) vary in their ability to completely resolve heartburn and other symptoms. Although…”
    Get full text
    Journal Article
  19. 19

    Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample by Hamilton, S H, Edgell, E T, Revicki, D A, Breier, A

    Published in International clinical psychopharmacology (01-09-2000)
    “…The primary aim of this study was to compare functional outcomes between patients with schizophrenia treated with olanzapine or haloperidol in Europe. The…”
    Get more information
    Journal Article
  20. 20

    Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials by Kimel, M, Hsieh, R, McCormack, J, Burch, S P, Revicki, D A

    Published in Cephalalgia (01-05-2008)
    “…This study was aimed to evaluate in clinical trial settings the psychometric properties of the revised Patient Perception of Migraine Questionnaire (PPMQ-R), a…”
    Get more information
    Journal Article